High Net Worth Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
2,411
+17
+0.7% +$17.2K 0.52% 51
2025
Q4
$2.57M Sell
2,394
-399
-14% -$382K 0.59% 45
2025
Q3
$2.13M Sell
2,793
-1,599
-36% -$1.19M 0.51% 51
2025
Q2
$3.42M Sell
4,392
-69
-2% -$53.6K 0.91% 30
2025
Q1
$3.69M Sell
4,461
-112
-2% -$93.2K 1.04% 26
2024
Q4
$3.53M Sell
4,573
-379
-8% -$314K 0.99% 26
2024
Q3
$4.39M Sell
4,952
-102
-2% -$91.7K 1.2% 21
2024
Q2
$4.58M Buy
5,054
+135
+3% +$108K 1.39% 19
2024
Q1
$3.83M Buy
4,919
+67
+1% +$47.7K 1.2% 23
2023
Q4
$2.83M Sell
4,852
-9
-0.2% -$5.25K 1.05% 24
2023
Q3
$2.61M Sell
4,861
-298
-6% -$154K 1.05% 22
2023
Q2
$2.42M Sell
5,159
-98
-2% -$41.1K 0.94% 25
2023
Q1
$1.81M Buy
5,257
+21
+0.4% +$7.08K 0.74% 38
2022
Q4
$1.92M Buy
5,236
+142
+3% +$50.3K 0.74% 30
2022
Q3
$1.65M Sell
5,094
-49
-1% -$15.5K 0.7% 36
2022
Q2
$1.67M Buy
5,143
+102
+2% +$30.6K 0.69% 38
2022
Q1
$1.44M Buy
5,041
+2
+0% +$515 0.52% 50
2021
Q4
$1.39M Buy
+5,039
New +$1.28M 0.49% 50

Other funds holding LLY

High Net Worth Advisory Group's LLY Position: Q1 2026 in Review

High Net Worth Advisory Group increased its Eli Lilly (LLY) stake by 0.71% in Q1 2026, buying an estimated $17.2K and bringing the position to 2,411 shares worth $2.22M. The position accounts for 0.52% of the portfolio, ranked #51.

High Net Worth Advisory Group first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.58M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • High Net Worth Advisory Group held 2,411 shares of Eli Lilly worth $2.22M as of Q1 2026.
  • High Net Worth Advisory Group bought 17 Eli Lilly shares in Q1 2026, an estimated $17.2K.
  • Eli Lilly made up 0.52% of High Net Worth Advisory Group's portfolio in Q1 2026, its #51 holding.
  • High Net Worth Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • High Net Worth Advisory Group's Eli Lilly position peaked at $4.58M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on High Net Worth Advisory Group's 13F filing for Q1 2026, filed 17 Apr 2026.